news - International Biopharmaceutical Industry

Current Edition

news

Napier launches AI/ML powered healthcare assistant

The Napier Assistant will be available to work with any third-party application to empower key users such as doctors and nurses. Leading Singapore-based healthcare ...

6 July 2018 news AI/ML | assistant

Continue Reading →

news

HUMAN VACCINES PROJECT AND SEQIRUS PARTNER TO ADVANCE UNIVERSAL FLU VACCINE RESEARCH

The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, and Seqirus, a global leader in the ...

5 July 2018 news advance | human

Continue Reading →

news

PharmaMar, Chugai terminate License Agreement for Zepsyre

PharmaMar announces that both Chugai and PharmaMar have entered into a mutual early termination agreement of this license agreement Chugai Pharmaceutical Co., Ltd. ...

29 June 2018 news agreement | chugai

Continue Reading →

news

Plasticell leads gene therapy manufacturing consortium

UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo gene therapies. Plasticell, a developer of st...

29 June 2018 news consortium | gene

Continue Reading →

news

NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S

NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 mill...

29 June 2018 news 20 | CHF

Continue Reading →

news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercia...

29 June 2018 news alvogen | announce

Continue Reading →

news

Immunotherapy advances spur new look at cancer vaccines

In an era of cancer immunotherapy, vaccines are getting fresh consideration as a therapeutic approach. Frustrated for years by lackluster results, cancer vaccine res...

29 June 2018 news advances | cancer

Continue Reading →

news

Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors

Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies,...

29 June 2018 news appoints | board

Continue Reading →

news

Lupin, Mylan to commercialize Enbrel Biosimilar

Under the terms of the agreement, Lupin will receive an up-front payment of $15 million. Pharma major Lupin Limited and global pharmaceutical company Mylan have a...

29 June 2018 news Biosimilar | commercialize

Continue Reading →

news

Aptamer Group: UK Biotech Business Raises $2.2M Investment

Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from ...

29 June 2018 news $2.2M | Aptamer

Continue Reading →